Compare Micron Technology, Inc. (MU) vs Vaxcyte Inc. Common Stock (PCVX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Micron Technology, Inc. vs Vaxcyte Inc. Common Stock — how do they compare? Micron Technology, Inc. trades at $879.44 (market cap $1.08T), while Vaxcyte Inc. Common Stock trades at $67.27 (market cap $10.51B). The key difference: Micron Technology, Inc. is far larger — about 102.8× Vaxcyte Inc. Common Stock's market cap, and Micron Technology, Inc. pays a 0.06% dividend while Vaxcyte Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Micron Technology, Inc. for 49 Days and Vaxcyte Inc. Common Stock for 0 Days on average.
| MU | PCVX | |
|---|---|---|
Market Cap | $1.08T | $10.51B |
Volume | 28,906,235 | 2,644,694 |
Sector | Technology | Health |
52-Week High | $1.21K | $73.82 |
52-Week Low | $191.94 | $40.32 |
Typical Hold Time | 49 Days | 0 Days |
Enterprise Value | $1.04T | $9.14B |
Dividend Yield | 0.06% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Micron Technology (MU) trades at $953.19, down 3.62% on the day, amid strong fundamentals including a P/E of 12.82 and net income margin of 63.8%. The stock has consistently beaten earnings estimates, with Q2 2026 EPS of $33.42 exceeding expectations. Technical indicators show a bullish moving average signal but neutral oscillators, with support at $954. Revenue surged to $37.38 billion in 2025, and cash flow from operations reached $17.53 billion, reflecting robust operational performance.
Outlook remains positive driven by AI memory demand and strategic customer agreements covering 35% of revenue through 2030. Risks include cyclical memory pricing and potential growth deceleration. Analyst consensus is strongly bullish with an average price target of $1,590, suggesting significant upside. Institutional sentiment supports growth, but investors should monitor competitive pressures and macroeconomic headwinds.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Micron Technology, Inc.
Micron historically focused on designing and manufacturing DRAM for PCs. The firm then expanded into the NAND flash memory market. It increased its DRAM scale with the purchase of Elpida (completed in mid-2013) and Inotera (completed in December 2016). The firm's DRAM and NAND products tailored to PCs, data centers, smartphones, game consoles, automotives, and other computing devices.
Read more on MU →About Vaxcyte Inc. Common Stock
Vaxcyte, Inc. is a clinical-stage vaccine company that engineers protein-based vaccines to prevent bacterial diseases such as invasive pneumococcal disease, using its proprietary cell-free protein synthesis platform to develop candidates including the pneumococcal conjugate vaccines VAX-31 and VAX-24.
Read more on PCVX →
